(Q37775961)

23 August 2017

1 reference

title

Anticipating drug side effects by comparative pharmacology (English)

1 reference

23 August 2017

1 reference

Jordi Mestres

2

0 references

Ricard Garcia-Serna

series ordinal

1

object named as

Ricard Garcia-Serna

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Expert Opinion on Drug Metabolism & Toxicology

23 August 2017

published in

1 reference

23 August 2017

volume

6

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

1253-1263

1 reference

Adverse drug reactions: definitions, diagnosis, and management

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

21 January 2018

When good drugs go bad.

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Drug repositioning: identifying and developing new uses for existing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Decision support methods for the detection of adverse events in post-marketing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Pharmacovigilance: methods, recent developments and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

hERG potassium channels and cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Drugs and valvular heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

A chemogenomic approach to drug discovery: focus on cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

The topology of drug-target interaction networks: implicit dependence on drug properties and target families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Relating protein pharmacology by ligand chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

A ligand-based approach to mining the chemogenomic space of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Drug target identification using side-effect similarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Predicting new molecular targets for known drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Analysis of drug-induced effect patterns to link structure and side effects of medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

In Silico Receptorome Screening of Antipsychotic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

iPHACE: integrative navigation in pharmacological space

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Mapping adverse drug reactions in chemical space.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Structure-Based Approaches to Target Fishing and Ligand Profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

A side effect resource to capture phenotypic effects of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Screening the receptorome reveals molecular targets responsible for drug-induced side effects: focus on 'fen-phen'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Bridging cheminformatic metabolite prediction and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Cytochrome P450 enzyme polymorphisms and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

A robustness-based approach to systems-oriented drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Predicting drug side-effects by chemical systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Genomic and personalized medicine: foundations and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

Data completeness—the Achilles heel of drug-target networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.509343

10.1517/17425255.2010.509343

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference